
MetLife, Inc. (NYSE:MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (&#34;Potemkin&#34;) to purchase up to 100,000 shares of MetLife, Inc. common stock from MetLife

<p xmlns="http://www.w3.org/1999/xhtml">
MetLife, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/MET">MET</a>) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited ("Potemkin") to purchase up to 100,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.02 percent of MetLife shares of common stock outstanding as of March 31, 2026. Potemkin's offer price of $44.20 per share is approximately 41.35 percent lower than the $75.36 closing price of MetLife common stock on April 13, 2026.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">MetLife does not endorse Potemkin's unsolicited mini-tender offer and recommends that shareholders do not tender their shares in response to Potemkin's offer because the offer is at a price that is significantly below the current market value of MetLife's common stock.</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
MetLife is not associated in any way with Potemkin, its mini-tender offer, or its mini-tender offer documents. Potemkin's offer is generally not subject to the information filing requirements of the Securities Exchange Act and Potemkin is not generally required to file reports, proxy statements and other information with the U.S. Securities and Exchange Commission (SEC) relating to its business, financial condition and otherwise.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Potemkin has made similar mini-tender offers for shares of other companies. Mini-tender offers, such as this one, seek to acquire less than five percent of a company's shares outstanding, thereby avoiding many disclosure and procedural requirements of the SEC. As a result, mini-tender offers do not provide investors with the same level of protections as provided by larger tender offers under U.S. securities laws.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The SEC has cautioned investors that some bidders making mini-tender offers at below-market prices are "hoping that they will catch investors off guard if the investors do not compare the offer price to the current market price." The SEC's cautionary advice to investors on mini-tender offers is available at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://www.sec.gov/investor/pubs/minitend.htm" shape="rect">https://www.sec.gov/investor/pubs/minitend.htm</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
MetLife urges investors to obtain current market quotations for their shares, consult with their broker or financial advisor, and exercise caution with respect to Potemkin's offer.

</p><p xmlns="http://www.w3.org/1999/xhtml">
MetLife urges shareholders who have not responded to Potemkin's offer to take no action. Shareholders who have already tendered their shares may withdraw them in the manner described in the Potemkin mini-tender offer documents, prior to the expiration of the offer, currently scheduled for Friday, March 26, 2027, at 5 p.m. Eastern time.

</p><p xmlns="http://www.w3.org/1999/xhtml">
MetLife encourages shareholders to review carefully the "Withdrawal Rights" section of the offer documents. MetLife encourages brokers and dealers, as well as other market participants, to review the SEC's letter regarding broker-dealer mini-tender offer dissemination and disclosure at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="http://www.sec.gov/divisions/marketreg/minitenders/sia072401.htm" shape="rect">www.sec.gov/divisions/marketreg/minitenders/sia072401.htm</a> and NASD's Notice to Members 99-53, issued July 1999, regarding guidance to members forwarding mini-tender offers to their customers, which can be found at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="http://www.finra.org/sites/default/files/NoticeDocument/p004221.pdf" shape="rect">http://www.finra.org/sites/default/files/NoticeDocument/p004221.pdf</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
MetLife requests that a copy of this news release be included with all distributions of materials relating to Potemkin's mini-tender offer related to shares of MetLife, Inc. common stock.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">About MetLife
<br xmlns="http://www.w3.org/1999/xhtml"></br></span>MetLife, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/MET">MET</a>), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="http://www.metlife.com" shape="rect">www.metlife.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260414252816r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260414252816/en/" rel="nofollow">https://www.businesswire.com/news/home/20260414252816/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">For Media: 
</b><br xmlns="http://www.w3.org/1999/xhtml"></br>Jane Slusark
<br xmlns="http://www.w3.org/1999/xhtml"></br>347-989-5477
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:Jane.Slusark@metlife.com" shape="rect">Jane.Slusark@metlife.com 
</a><br xmlns="http://www.w3.org/1999/xhtml"></br>
<br xmlns="http://www.w3.org/1999/xhtml"></br><b xmlns="http://www.w3.org/1999/xhtml">For Investors: 
</b><br xmlns="http://www.w3.org/1999/xhtml"></br>John Hall
<br xmlns="http://www.w3.org/1999/xhtml"></br>212-578-7888
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:John.A.Hall@metlife.com" shape="rect">John.A.Hall@metlife.com</a>

</p>

MetLife Recommends Shareholders Reject "Mini-Tender" Offer by Potemkin Limited

MetLife Urges Shareholders to Reject Low Mini-Tender Offer

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>MetLife, Inc. (NYSE:MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (&amp;#34;Potemkin&amp;#34;) to purchase up to 100,000 shares of MetLife, Inc. common stock from MetLife</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>MetLife has received a mini-tender offer from Potemkin Limited to purchase shares at $44.20, significantly below the current market price of $75.36. MetLife strongly advises shareholders to ignore this offer, as it does not reflect the true value of their shares, which could lead to investor losses if accepted.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Potemkin Limited has made a mini-tender offer for 100,000 MET shares.</li><li>The offer price is $44.20, significantly below MET&#039;s closing price of $75.36.</li><li>MetLife advises shareholders to reject Potemkin&#039;s offer and not tender shares.</li><li>The mini-tender offer lacks the disclosure protections of larger offers.</li><li>Investors are warned to evaluate the offer cautiously and seek market quotes.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Potemkin Limited (N/A)</strong>: Making a low mini-tender offer for MET shares.</li><li><strong>MetLife, Inc. (MET)</strong>: Firmly opposing the mini-tender offer to protect shareholders.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>This news falls under &#039;Corporate Developments&#039; due to MetLife&#039;s active response to an unsolicited offer affecting shareholder interests. MetLife&#039;s stance reflects its commitment to maintaining investor trust and stock value.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Potemkin&#039;s low offer may trigger volatility if share tendering occurs.</li><li>Rejecting the offer may maintain or bolster MET&#039;s stock price confidence.</li><li>Investor sentiment could shift positively with awareness of the SEC&#039;s caution against mini-tender offers.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Potemkin&#039;s offer price: $44.20 per share, a 41.35% discount from $75.36.</li><li>Offer represents only 0.02% of MetLife&#039;s shares outstanding.</li><li>Current claim date of occurrence: April 13, 2026.</li><li>Offer withdrawal deadline is March 26, 2027, at 5 p.m. Eastern.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Investors should hold MET shares, anticipating price stability as the offer is disregarded.</p>
  </section>
</section>


<p xmlns="http://www.w3.org/1999/xhtml">
MetLife, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/MET">MET</a>) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited ("Potemkin") to purchase up to 100,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.02 percent of MetLife shares of common stock outstanding as of March 31, 2026. Potemkin's offer price of $44.20 per share is approximately 41.35 percent lower than the $75.36 closing price of MetLife common stock on April 13, 2026.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">MetLife does not endorse Potemkin's unsolicited mini-tender offer and recommends that shareholders do not tender their shares in response to Potemkin's offer because the offer is at a price that is significantly below the current market value of MetLife's common stock.</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
MetLife is not associated in any way with Potemkin, its mini-tender offer, or its mini-tender offer documents. Potemkin's offer is generally not subject to the information filing requirements of the Securities Exchange Act and Potemkin is not generally required to file reports, proxy statements and other information with the U.S. Securities and Exchange Commission (SEC) relating to its business, financial condition and otherwise.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Potemkin has made similar mini-tender offers for shares of other companies. Mini-tender offers, such as this one, seek to acquire less than five percent of a company's shares outstanding, thereby avoiding many disclosure and procedural requirements of the SEC. As a result, mini-tender offers do not provide investors with the same level of protections as provided by larger tender offers under U.S. securities laws.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The SEC has cautioned investors that some bidders making mini-tender offers at below-market prices are "hoping that they will catch investors off guard if the investors do not compare the offer price to the current market price." The SEC's cautionary advice to investors on mini-tender offers is available at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://www.sec.gov/investor/pubs/minitend.htm" shape="rect">https://www.sec.gov/investor/pubs/minitend.htm</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
MetLife urges investors to obtain current market quotations for their shares, consult with their broker or financial advisor, and exercise caution with respect to Potemkin's offer.

</p><p xmlns="http://www.w3.org/1999/xhtml">
MetLife urges shareholders who have not responded to Potemkin's offer to take no action. Shareholders who have already tendered their shares may withdraw them in the manner described in the Potemkin mini-tender offer documents, prior to the expiration of the offer, currently scheduled for Friday, March 26, 2027, at 5 p.m. Eastern time.

</p><p xmlns="http://www.w3.org/1999/xhtml">
MetLife encourages shareholders to review carefully the "Withdrawal Rights" section of the offer documents. MetLife encourages brokers and dealers, as well as other market participants, to review the SEC's letter regarding broker-dealer mini-tender offer dissemination and disclosure at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="http://www.sec.gov/divisions/marketreg/minitenders/sia072401.htm" shape="rect">www.sec.gov/divisions/marketreg/minitenders/sia072401.htm</a> and NASD's Notice to Members 99-53, issued July 1999, regarding guidance to members forwarding mini-tender offers to their customers, which can be found at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="http://www.finra.org/sites/default/files/NoticeDocument/p004221.pdf" shape="rect">http://www.finra.org/sites/default/files/NoticeDocument/p004221.pdf</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
MetLife requests that a copy of this news release be included with all distributions of materials relating to Potemkin's mini-tender offer related to shares of MetLife, Inc. common stock.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">About MetLife
<br xmlns="http://www.w3.org/1999/xhtml"></br></span>MetLife, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/MET">MET</a>), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="http://www.metlife.com" shape="rect">www.metlife.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260414252816r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260414252816/en/" rel="nofollow">https://www.businesswire.com/news/home/20260414252816/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">For Media: 
</b><br xmlns="http://www.w3.org/1999/xhtml"></br>Jane Slusark
<br xmlns="http://www.w3.org/1999/xhtml"></br>347-989-5477
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:Jane.Slusark@metlife.com" shape="rect">Jane.Slusark@metlife.com 
</a><br xmlns="http://www.w3.org/1999/xhtml"></br>
<br xmlns="http://www.w3.org/1999/xhtml"></br><b xmlns="http://www.w3.org/1999/xhtml">For Investors: 
</b><br xmlns="http://www.w3.org/1999/xhtml"></br>John Hall
<br xmlns="http://www.w3.org/1999/xhtml"></br>212-578-7888
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:John.A.Hall@metlife.com" shape="rect">John.A.Hall@metlife.com</a>

</p>

MetLife has received a mini-tender offer from Potemkin Limited to purchase shares at $44.20, significantly below the current market price of $75.36. MetLife strongly advises shareholders to ignore this offer, as it does not reflect the true value of their shares, which could lead to investor losses if accepted.

MetLife Recommends Shareholders Reject "Mini-Tender" Offer by Potemkin Limited

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News